← All trials
NCT05822583
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 6, 2023
- Primary completion
- Jul 1, 2025
- Completion date
- Jul 1, 2025
- First posted
- Apr 21, 2023
- Last posted
- Dec 29, 2023
- Enrollment
- 1500
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of MinnesotaLead sponsor
- University of CopenhagenOverall official - principal investigator
- University of MinnesotaStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.